Ignite Creation Date:
2024-05-06 @ 10:34 AM
Last Modification Date:
2024-10-26 @ 12:32 PM
Study NCT ID:
NCT03297580
Status:
COMPLETED
Last Update Posted:
2017-09-29
First Post:
2017-09-20
Brief Title:
Itch and Clinacal Caracteristics in Systemic Sclerosis
Sponsor:
University Hospital Brest
Organization:
University Hospital Brest
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2017-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SCLERODERMIE
Brief Summary:
Systemic sclerosis SSc has heterogeneous symptoms and significant medical morbidity Recently itch was described as a symptom of SSc prevalence of 426 To the investigators knowledge no study yet has examined the clinical features of itch neither had used a specific itch-related quality of life QoL scales in patients with SSc The objectives were to evaluate the prevalence of pruritus its characteristics and its impact on the QoL in those patients
In this descriptive study patients followed for SSc in the departments of dermatology rheumatology internal medicine and pulmonology at the University Hospital of Brest were included Participants received a questionnaire including questions about the clinical features of pruritus and 2 scores 5-D itch scale ItchyQol
In this descriptive study patients followed for SSc in the departments of dermatology rheumatology internal medicine and pulmonology at the University Hospital of Brest were included Participants received a questionnaire including questions about the clinical features of pruritus and 2 scores 5-D itch scale ItchyQol
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None